Memorandum Of UnderstandingsWize Pharma, Inc. • April 1st, 2019 • Pharmaceutical preparations
Company FiledApril 1st, 2019 IndustryThis memorandum of understanding (this “MOU”) is entered on February 24, 2019 and is intended to reflect our mutual agreement between Resdevco, Research and Development Ltd. (Private Company 510422223, hereinafter “Resdevco”) to Wize Pharma Ltd. of Hanagar Hod Hasharon, Israel (“Wize”).